top of page
PROJECT MARKETPLACE
In silico docking of COX-2 inhibitors to assess anti-metastatic potential in colorectal cancer (1)Date and time is TBDOn Going Project
Microbiome and Personalized Medicine (1)Date and time is TBDOn Going Project
Reverse docking of immunosuppressants to identify multi-target anti-cancer mechanisms.Thu, 24 AprOn Going Research
Docking of proteasome inhibitors for multiple myeloma using transcriptomic-guided selection.Thu, 24 AprOn Going Project
Virtual screening of FDA-approved tyrosine kinase inhibitors against new fusion oncogenes.Thu, 24 AprOn Going Project
Docking of CRISPR-identified candidate targets with kinase inhibitor libraries.Thu, 24 AprOn Going Project
Connectivity Map-based docking of anti-diabetics targeting MAPK pathway kinases.Thu, 24 AprOn Going Project
Repurposing antidepressants as inhibitors of mTOR signaling in breast cancerThu, 24 AprOn Going Project
Targeting EGFR mutations using known anti-inflammatory compounds (e.g., curcumin derivatives).Thu, 24 AprOn Going Project
Docking of Repurposed JAK Inhibitors on JAK/STAT Pathway Proteins in LeukemiaThu, 24 AprOn Going Study
CRISPR Gene Editing for Genetic DisordersThu, 10 AprOn Going Project
AI-Assisted Drug DiscoveryThu, 10 AprOn Going Project
Climate Change & Infectious DiseasesThu, 10 AprOn Going Project
Waterborne Diseases & Nanotechnology SolutionsThu, 10 AprOn Going Project
Neurotechnology for Brain-Computer InterfaceThu, 10 AprOn Going Project
Lab-Grown Meat & Cellular AgricultureThu, 10 AprOn Going Project
AI-Powered Disease DiagnosisThu, 10 AprOn Going Project
bottom of page